Organogenesis Holdings Inc.
ORGO
$4.82
$0.153.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 100.78M | 86.69M | 126.66M | 115.18M | 130.23M |
| Total Other Revenue | 226.00K | -- | -- | -- | -- |
| Total Revenue | 101.01M | 86.69M | 126.66M | 115.18M | 130.23M |
| Cost of Revenue | 27.63M | 23.72M | 31.05M | 26.80M | 29.20M |
| Gross Profit | 73.38M | 62.97M | 95.61M | 88.38M | 101.04M |
| SG&A Expenses | 73.81M | 72.51M | 73.86M | 71.80M | 76.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 111.84M | 106.87M | 116.44M | 108.94M | 121.33M |
| Operating Income | -10.83M | -20.18M | 10.22M | 6.24M | 8.91M |
| Income Before Tax | -11.83M | -25.78M | 10.25M | 5.82M | -14.54M |
| Income Tax Expenses | -2.44M | -6.94M | 2.58M | -6.51M | 2.50M |
| Earnings from Continuing Operations | -9.39M | -18.84M | 7.67M | 12.33M | -17.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.39M | -18.84M | 7.67M | 12.33M | -17.04M |
| EBIT | -10.83M | -20.18M | 10.22M | 6.24M | 8.91M |
| EBITDA | -6.26M | -15.89M | 14.67M | 10.65M | 13.11M |
| EPS Basic | -0.10 | -0.17 | 0.05 | 0.09 | -0.13 |
| Normalized Basic EPS | -0.05 | -0.10 | 0.05 | 0.03 | 0.04 |
| EPS Diluted | -0.10 | -0.17 | 0.04 | 0.09 | -0.13 |
| Normalized Diluted EPS | -0.05 | -0.10 | 0.05 | 0.03 | 0.04 |
| Average Basic Shares Outstanding | 126.85M | 126.30M | 129.68M | 132.58M | 132.57M |
| Average Diluted Shares Outstanding | 126.85M | 126.30M | 132.16M | 133.93M | 132.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |